This is in reference to letter dated 29 February 2020 intimating the date of the Board Meeting for consideration of Appointment of Chief Financial Officer (CFO) of the Company. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the Appointment of Sahil Shah as a Chief Financial Officer (KMP) the Company with effect from 01 March 2020. The details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as enclosed. The company has attached Press Release issued in this regard.
The above information is a part of company’s filings submitted to BSE.
